Editorial for Special Issue-"Early-Stage Drug Discovery: Advances and Challenges".
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
30 Mar 2023
30 Mar 2023
Historique:
received:
27
03
2023
accepted:
30
03
2023
medline:
14
4
2023
entrez:
13
4
2023
pubmed:
14
4
2023
Statut:
epublish
Résumé
The development of a new drug from the first hit to the launch of an approved product is a complex process that usually take around 12-15 years and costs more than USD 1-2 billion [...].
Identifiants
pubmed: 37047488
pii: ijms24076516
doi: 10.3390/ijms24076516
pmc: PMC10094839
pii:
doi:
Types de publication
Editorial
Langues
eng
Sous-ensembles de citation
IM
Références
Int J Mol Sci. 2022 Aug 25;23(17):
pubmed: 36077056
Int J Mol Sci. 2023 Mar 22;24(6):
pubmed: 36983037
Int J Mol Sci. 2022 Dec 09;23(24):
pubmed: 36555297
Int J Mol Sci. 2021 Dec 29;23(1):
pubmed: 35008795
Int J Mol Sci. 2023 Feb 17;24(4):
pubmed: 36835453
Int J Mol Sci. 2022 Sep 21;23(19):
pubmed: 36232374
Int J Mol Sci. 2022 Nov 27;23(23):
pubmed: 36499165
Int J Mol Sci. 2023 Jan 19;24(3):
pubmed: 36768348
Int J Mol Sci. 2023 Mar 01;24(5):
pubmed: 36902164
Int J Mol Sci. 2023 Jan 19;24(3):
pubmed: 36768346